Co-Diagnostics, Inc. Increase (Decrease) in Prepaid Expense
Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Prepaid Expense of $23.01 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-13
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was $26.29K.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$3.28K.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$655.51K, a 404.44% decline year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $759.59K.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for fiscal 2025 was -$585.93K.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$412.06K.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for fiscal 2023 was -$1.08M, a 583.07% decline from fiscal 2022.
- Co-Diagnostics, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $224.09K, a 89.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $26.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $23.01K 10-Q · filed 2026-08-13 | -$632.50K derived: sum of 3 quarters · filed 2026-08-13 | $127.10K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$3.28K 10-Q · filed 2026-05-14 | -$658.79K derived: sum of 2 quarters · filed 2026-05-14 | $100.81K derived: sum of 3 quarters · filed 2026-05-14 | -$383.30K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | -$655.51K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $104.08K derived: sum of 2 quarters · filed 2026-03-31 | -$380.02K derived: sum of 3 quarters · filed 2026-08-13 | -$585.93K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $759.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $275.49K derived: sum of 2 quarters · filed 2026-08-13 | $69.58K 10-Q · filed 2025-11-13 | $284.90K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$484.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$690.01K 10-Q · filed 2026-08-13 | -$474.70K derived: sum of 3 quarters · filed 2026-08-13 | -$802.10K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$205.91K 10-Q · filed 2026-05-14 | $9.41K derived: sum of 2 quarters · filed 2026-05-14 | -$317.99K derived: sum of 3 quarters · filed 2026-05-14 | -$744.36K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $215.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$112.09K derived: sum of 2 quarters · filed 2026-03-31 | -$538.46K derived: sum of 3 quarters · filed 2026-03-31 | -$412.06K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$327.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$753.77K derived: sum of 2 quarters · filed 2025-11-13 | -$627.37K 10-Q · filed 2025-11-13 | -$1.56M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$426.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$299.97K 10-Q · filed 2025-08-14 | -$1.23M derived: sum of 3 quarters · filed 2025-08-14 | -$1.13M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $126.40K 10-Q · filed 2025-05-08 | -$804.28K derived: sum of 2 quarters · filed 2025-05-08 | -$708.48K derived: sum of 3 quarters · filed 2025-05-08 | -$895.69K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$930.68K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$834.88K derived: sum of 2 quarters · filed 2025-03-27 | -$1.02M derived: sum of 3 quarters · filed 2025-03-27 | -$1.08M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $95.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$91.41K derived: sum of 2 quarters · filed 2024-11-07 | -$151.86K 10-Q · filed 2024-11-07 | $514.02K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$187.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$247.66K 10-Q · filed 2024-08-08 | $418.22K derived: sum of 3 quarters · filed 2024-08-08 | $767.89K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$60.45K 10-Q · filed 2024-05-09 | $605.43K derived: sum of 2 quarters · filed 2024-05-09 | $955.10K derived: sum of 3 quarters · filed 2024-05-09 | $1.21M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $665.88K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.02M derived: sum of 2 quarters · filed 2024-03-14 | $1.27M derived: sum of 3 quarters · filed 2024-03-14 | $224.09K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $349.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $601.15K derived: sum of 2 quarters · filed 2023-11-09 | -$441.79K 10-Q · filed 2023-11-09 | $1.49M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $251.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$791.45K 10-Q · filed 2023-08-10 | -$791.95K 10-Q · filed 2022-08-11 | $1.14M derived: sum of 3 quarters · filed 2023-08-10 | $587.16K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$1.04M 10-Q · filed 2023-05-11 | $890.10K derived: sum of 2 quarters · filed 2023-05-11 | $335.69K derived: sum of 3 quarters · filed 2023-05-11 | $891.69K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.38M derived: sum of 2 quarters · filed 2023-03-16 | $1.93M derived: sum of 3 quarters · filed 2023-03-16 | $2.05M 10-K · filed 2023-03-16 | |
| 2021-09-30 | -$554.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.59K derived: sum of 2 quarters · filed 2022-11-10 | $116.07K 10-Q · filed 2022-11-10 | $100.45K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $556.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $670.48K 10-Q · filed 2022-08-11 | $654.86K derived: sum of 3 quarters · filed 2022-08-11 | -$1.85M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $114.47K 10-Q · filed 2022-05-12 | $98.86K derived: sum of 2 quarters · filed 2022-05-12 | -$2.41M derived: sum of 3 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$15.61K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$2.52M derived: sum of 2 quarters · filed 2022-03-24 | $6.46K 10-K · filed 2022-03-24 | ||
| 2020-09-30 | -$2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $22.08K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $2.53M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |